Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydiane Mondot

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2019
<sup>18</sup>F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisionsOlivier Humbert, Véronique Bourg, Lydiane Mondot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2019
Correction to: <sup>18</sup>F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisionsOlivier Humbert, Véronique Bourg, Lydiane Mondot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2023
Added value of [<sup>18</sup>F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre studyJacques Darcourt, David Chardin, Véronique Bourg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2026
Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examinationMikael Cohen, Lydiane Mondot, Xavier Ayrignac, et al.
Annals of Clinical and Translational Neurology|June 2, 2026
Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic ImpactChristine Lebrun-Frenay, Cassandre Landes-Château, Lydiane Mondot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndromeCassandre Landes-Château, Vito Ag Ricigliano, Lydiane Mondot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2020
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MSMikael Cohen, Lydiane Mondot, Florence Bucciarelli, et al.
Neurology and Therapy|February 10, 2023
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French CohortJuliette Pelle, Anais R Briant, Pierre Branger, et al.
Brain : a Journal of Neurology|March 3, 2023
The radiologically isolated syndrome: revised diagnostic criteriaChristine Lebrun-Frénay, Darin T Okuda, Aksel Siva, et al.
JAMA Neurology|August 21, 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical TrialChristine Lebrun-Frénay, Aksel Siva, Maria Pia Sormani, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|January 7, 2019
<sup>18</sup>F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisionsOlivier Humbert, Véronique Bourg, Lydiane Mondot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 14, 2019
Correction to: <sup>18</sup>F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisionsOlivier Humbert, Véronique Bourg, Lydiane Mondot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 22, 2023
Added value of [<sup>18</sup>F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre studyJacques Darcourt, David Chardin, Véronique Bourg, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2026
Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examinationMikael Cohen, Lydiane Mondot, Xavier Ayrignac, et al.
Annals of Clinical and Translational Neurology|June 2, 2026
Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic ImpactChristine Lebrun-Frenay, Cassandre Landes-Château, Lydiane Mondot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 9, 2024
Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndromeCassandre Landes-Château, Vito Ag Ricigliano, Lydiane Mondot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2020
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MSMikael Cohen, Lydiane Mondot, Florence Bucciarelli, et al.
Neurology and Therapy|February 10, 2023
Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French CohortJuliette Pelle, Anais R Briant, Pierre Branger, et al.
Brain : a Journal of Neurology|March 3, 2023
The radiologically isolated syndrome: revised diagnostic criteriaChristine Lebrun-Frénay, Darin T Okuda, Aksel Siva, et al.
JAMA Neurology|August 21, 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical TrialChristine Lebrun-Frénay, Aksel Siva, Maria Pia Sormani, et al.
Pageof 5